CD8A and cancer: Overall, our study convincingly demonstrated that CD8A has enormous potential as a robust biomarker predicting cancer patient survival outcome and their clinical stage, with additional data indicating that CD8A was implicated in forming an immunosuppressive environment through T cell exclusion in TME.